Head, Oncology Clinical Development - ADCs
Lead the clinical development strategy for antibody-drug conjugates (ADCs) across multiple tumor types, from early-phase through registrational trials and market launch. Drive integrated clinical and translational research, represent the asset at key governance forums, and shape portfolio-level decision-making in oncology. Work across global cross-functional teams to advance innovative therapies within a matrixed biopharma environment.